Survival and Characteristics of Bladder Cancer: Analysis of the Malaysian National Cancer Registry
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Area
2.2. Study Design
2.3. Statistical Analysis
2.4. Ethical Approval
3. Results
3.1. Characteristics
3.2. Five-Year Observed Survival
3.3. Median Survival Time
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Noone, A.; Howlader, N.; Krapcho, M.; Miller, D.; Brest, A.; Yu, M. SEER Cancer Statistics Review, 1975–2015; Based on November 2017 SEER Data Submission, Posted to the SEER Web Site, April 2018; National Cancer Institute: Bethesda, MD, USA, 2018.
- Nielsen, M.E.; Smith, A.B.; Meyer, A.-M.; Kuo, T.-M.; Tyree, S.; Kim, W.Y.; Milowsky, M.I.; Pruthi, R.S.; Millikan, R.C. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006. Cancer 2014, 120, 86–95. [Google Scholar] [CrossRef] [PubMed]
- Joung, J.Y.; Lim, J.; Oh, C.-M.; Jung, K.-W.; Cho, H.; Kim, S.H.; Seo, H.K.; Park, W.S.; Chung, J.; Lee, K.H.; et al. Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea. Cancer Res. Treat. 2017, 49, 607–615. [Google Scholar] [CrossRef]
- Department of Statistics Malaysia. Press Release Population Projection (Revised), Malaysia, 2010–2040; Department of Statistics: Putrajaya, Malaysia, 2016. Available online: https://www.dosm.gov.my/v1/index.php?r=column/cthemeByCat&cat=118&bul_id=Y3kwU2tSNVFDOWp1YmtZYnhUeVBEdz09&menu_id=L0pheU43NWJwRWVSZklWdzQ4TlhUUT09 (accessed on 15 March 2019).
- Antoni, S.; Ferlay, J.; Soerjomataram, I.; Znaor, A.; Jemal, A.; Bray, F. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur. Urol. 2017, 71, 96–108. [Google Scholar] [CrossRef]
- Ploeg, M.; Aben, K.K.; Hulsbergen-van de Kaa, C.A.; Schoenberg, M.P.; Witjes, J.A.; Kiemeney, L.A. Clinical Epidemiology of Nonurothelial Bladder Cancer: Analysis of The Netherlands Cancer Registry. J. Urol. 2010, 183, 915–920. [Google Scholar] [CrossRef] [PubMed]
- Royce, T.J.; Lin, C.C.; Gray, P.J.; Shipley, W.U.; Jemal, A.; Efstathiou, J.A. Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Data Base. Urol. Oncol. Semin. Orig. Investig. 2018, 36, 78.e1–78.e12. [Google Scholar] [CrossRef]
- Kong, C.H.C.; Singam, P.; Hong, G.E.; Cheok, L.B.; Azrif, M.; Tamil, A.M.; Zainuddin, Z.M. Clinicopathological features of bladder tumours in a single institution in Malaysia. Asian Pac. J. Cancer Prev. 2010, 11, 149–152. [Google Scholar]
- Singapore Cancer Registry. Singapore Cancer Registry Cancer Survival in Singapore 1973–2012; National Registry of Diseases Office, Ministry of Health: Singapore, 2015. Available online: https://www.nrdo.gov.sg/publications/cancer (accessed on 7 October 2018).
- Zaitsu, M.; Toyokawa, S.; Tonooka, A.; Nakamura, F.; Takeuchi, T.; Homma, Y.; Kobayashi, Y. Sex differences in bladder cancer pathology and survival: Analysis of a population-based cancer registry. Cancer Med. 2015, 4, 363–370. [Google Scholar] [CrossRef]
- Belgian Cancer Registry. Cancer Survival in Belgium; Belgian Cancer Registry: Brussel, Belgium, 2012; Available online: http://www.kankerregister.org/media/docs/publications/CancerSurvivalinBelgium.PDF (accessed on 24 September 2018).
- ISD Scotland. Cancer Survival in Scotland 1987–2011; Information Services Division (ISD), NHS Scotland: Scotland, UK, 2015; Available online: https://www.isdscotland.org/Health-Topics/Cancer/Publications/2015-03-03/2015-03-03-CancerSurvival-Report.pdf? (accessed on 7 October 2018).
- Lund, L.; Erichsen, R.; Nørgaard, M.; Larsen, E.; Borre, M.; Jacobsen, J. Survival of invasive bladder cancer patients, 1998-2009; a central and northern Denmark population-based cohort study. Clin. Epidemiol. 2011, 3, 47–51. [Google Scholar] [CrossRef][Green Version]
- Mokhtar, A.; Al Alawi, M.M.; Al Taweel, W.M.; Al Othman, K.; Kattan, S.A.; Al Otaibi, M.F. Is survival after radical cystectomy for bladder cancer in Saudi patients different from that of Western patients? Ann. Saudi Med. 2017, 37, 194–200. [Google Scholar] [CrossRef]
- Supit, W.; Mochtar, C.A.; Santoso, R.B.; Umbas, R. Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder. Asian J. Surg. 2014, 37, 184–189. [Google Scholar] [CrossRef]
- Vahedian-Ardakani, H.-A.; Moghimi, M.; Shayestehpour, M.; Doosti, M.; Alimohammadi, F. Survival Rate of Patients with Bladder Cancer in Yazd, Central Province of Iran. 2018. Available online: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048710356&doi=10.5812%2Fijcm.61436&partnerID=40&md5=f6daf89cf694d7e6ebafcebc489857c5 (accessed on 7 October 2018).
- Haque, W.; Verma, V.; Butler, E.B.; Teh, B.S. Radical Cystectomy Versus Chemoradiation for Muscle-invasive Bladder Cancer: Impact of Treatment Facility and Sociodemographics. Anticancer Res. 2017, 37, 5603–5608. [Google Scholar]
- Kozak, K.R.; Hamidi, M.; Manning, M.; Moody, J.S. Bladder preservation for localised muscle-invasive bladder cancer: The survival impact of local utilisation rates of definitive radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2012, 83, 1–18. [Google Scholar] [CrossRef]
- Smith, A.B.; Deal, A.M.; Woods, M.E.; Wallen, E.M.; Pruthi, R.S.; Chen, R.C.; Milowsky, M.I.; Nielsen, M.E. Muscle-invasive bladder cancer: Evaluating treatment and survival in the National Cancer Data Base. BJU Int. 2014, 114, 719–726. [Google Scholar] [CrossRef]
- Zakaria, A.S.; Santos, F.; Kassouf, W.; Tanguay, S.; Aprikian, A. Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec. Urol. Int. 2016, 97, 49–53. [Google Scholar] [CrossRef]
- Fisher, M.D.; Shenolikar, R.; Miller, P.J.; Fenton, M.; Walker, M.S. Treatment Patterns and Outcomes in Stage IV Bladder Cancer in a Community Oncology Setting: 2008–2015. Clin. Genitourin. Cancer 2018, 16, e1171–e1179. [Google Scholar] [CrossRef] [PubMed]
- Flannery, K.; Cao, X.; He, J.; Zhong, Y.; Shah, A.Y.; Kamat, A.M. Survival Rates and Health Care Costs for Patients With Advanced Bladder Cancer Treated and Untreated With Chemotherapy. Clin. Genitourin. Cancer 2018, 16, e909–e917. [Google Scholar] [CrossRef]
- Haque, W.; Verma, V.; Butler, E.B.; Teh, B.S. National Practice Patterns and Outcomes for T4b Urothelial Cancer of the Bladder. Clin. Genitourin. Cancer 2018, 16, 42–49.e1. [Google Scholar] [CrossRef]
- Allemani, C.; Matsuda, T.; Di Carlo, V.; Harewood, R.; Matz, M.; Nikšić, M.; Bonaventure, A.; Valkov, M.; Johnson, C.J.; Estève, J.; et al. Global surveillance of trends in cancer survival 2000–2014 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 2018, 391, 1023–1075. [Google Scholar] [CrossRef]
- National Cancer Institute Ministry of Health Malaysia. Malaysian Study on Cancer Survival (MySCan); National Cancer Institute Ministry of Health Malaysia: Putrajaya, Malaysia, 2018. Available online: http://nci.moh.gov.my/index.php/ms/main-menu-2/laporan (accessed on 7 October 2018).
- Roubaud, G.; Brouste, V.; Beuzeboc, P.; Fléchon, A.; Tosi, D.; Lavau-Denes, S.; Chevreau, C.; Culine, S.; Oudard, S.; Quivy, A.; et al. Early objective response may not be a prognostic factor of survival for patients with metastatic urothelial carcinoma: From a retrospective analysis of a cohort of 113 patients. J. Negat. Results Biomed. 2015, 14, 1–7. [Google Scholar] [CrossRef]
- Krause, F.S.; Walter, B.; Ott, O.J.; Häberle, L.; Weiss, C.; Rödel, C.; Wullich, B.; Sauer, R. 15-Year Survival Rates After Transurethral Resection and Radiochemotherapy or Radiation in Bladder Cancer Treatment. Anticancer Res. 2011, 31, 985–990. [Google Scholar]
- Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [PubMed]
- Keck, B.; Ott, O.J.; Häberle, L.; Kunath, F.; Weiss, C.; Rödel, C.; Sauer, R.; Fietkau, R.; Wullich, B.; Krause, F.S. Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy. World J. Urol. 2013, 31, 1023–1028. [Google Scholar] [CrossRef]
- Cumberbatch, M.G.K.; Noon, A.P. Epidemiology, aetiology and screening of bladder cancer. Transl. Androl. Urol. 2019, 8, 5–11. [Google Scholar] [CrossRef] [PubMed]
- Dobruch, J.; Daneshmand, S.; Fisch, M.; Lotan, Y.; Noon, A.P.; Resnick, M.J.; Shariat, S.F.; Zlotta, A.R.; Boorjian, S.A. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. Eur. Urol. 2016, 69, 300–310. [Google Scholar] [CrossRef] [PubMed]
- Rose, T.L.; Deal, A.M.; Nielsen, M.E.; Smith, A.B.; Milowsky, M.I. Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer. Cancer 2016, 122, 2012–2020. [Google Scholar] [CrossRef] [PubMed]
- Minicozzi, P.; Innos, K.; Sánchez, M.J.; Trama, A.; Walsh, P.M.; Marcos-Gragera, R.; Dimitrova, N.; Botta, L.; Visser, O.; Rossi, S.; et al. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study. Eur. J. Cancer 2017, 84, 335–353. [Google Scholar] [CrossRef]
- Andreassen, B.K.; Aagnes, B.; Gislefoss, R.; Andreassen, M.; Wahlqvist, R. Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981–2014. BMC Cancer 2016, 16, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Patel, M.I.; Bang, A.; Gillett, D.; Cheluvappa, R.; Smith, D.P. Poor survival of females with bladder cancer is limited to those aged 70 years or over: A population-wide linkage study, New South Wales, Australia. Cancer Med. 2015, 4, 1145–1152. [Google Scholar] [CrossRef]
- Marcos-Gragera, R.; Mallone, S.; Kiemeney, L.A.; Vilardell, L.; Malats, N.; Allory, Y.; Sant, M.; Hackl, M.; Zielonke, N.; Oberaigner, W.; et al. Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5. Eur. J. Cancer 2015, 51, 2217–2230. [Google Scholar] [CrossRef]
Characteristics | n (%) |
---|---|
Age (mean, SD) | 64.9 (12.5) |
Sex | |
Male | 1438 (78.7) |
Female | 390 (21.3) |
Ethnicity | |
Malay | 903 (49.4) |
Chinese | 684 (37.4) |
Indian | 107 (5.9) |
Iban | 36 (2.0) |
Kadazan | 17 (0.9) |
Others | 81 (4.4) |
Morphology | |
Urothelial carcinoma | 1430 (78.2) |
Squamous cell carcinoma | 57 (3.1) |
Adenocarcinoma | 150 (8.2) |
Sarcoma | 10 (0.6) |
Others | 7 (0.4) |
Nonspecific | 174 (9.5) |
Stage | |
I | 270 (14.8) |
II | 216 (11.8) |
III | 153 (8.4) |
IV | 250 (13.7) |
Unrecorded | 939 (51.4) |
Surgery | |
Yes | 902 (49.3) |
No | 297 (16.3) |
Unrecorded | 629 (34.4) |
Radiotherapy | |
Yes | 221 (12.1) |
No | 573 (31.3) |
Unrecorded | 1034 (56.6) |
Chemotherapy | |
Yes | 191 (10.5) |
No | 587 (32.1) |
Unrecorded | 1050 (57.4) |
Stage | Five-Year Survival % (95% CI) | Median Survival Time Months (95% CI) |
---|---|---|
I | 67.6 (62.0, 73.3) | - |
II | 34.3 (27.9, 40.8) | 27.6 (18.1, 37.0) |
III | 25.7 (18.7, 32.6) | 17.0 (13.3, 20.7) |
IV | 12.2 (8.1, 16.3) | 8.8 (7.0, 10.7) |
Unrecorded | 36.9 (33.7, 40.1) | 29.3 (23.5, 31.0) |
All | 36.9% (95% CI: 34.6, 39.1) | 27.3 (23.6, 31.0) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Nik Ab Kadir, M.N.; Mohd Hairon, S.; Yaacob, N.M.; Ab Manan, A.; Ali, N. Survival and Characteristics of Bladder Cancer: Analysis of the Malaysian National Cancer Registry. Int. J. Environ. Res. Public Health 2021, 18, 5237. https://doi.org/10.3390/ijerph18105237
Nik Ab Kadir MN, Mohd Hairon S, Yaacob NM, Ab Manan A, Ali N. Survival and Characteristics of Bladder Cancer: Analysis of the Malaysian National Cancer Registry. International Journal of Environmental Research and Public Health. 2021; 18(10):5237. https://doi.org/10.3390/ijerph18105237
Chicago/Turabian StyleNik Ab Kadir, Mohd Nasrullah, Suhaily Mohd Hairon, Najib Majdi Yaacob, Azizah Ab Manan, and Nabihah Ali. 2021. "Survival and Characteristics of Bladder Cancer: Analysis of the Malaysian National Cancer Registry" International Journal of Environmental Research and Public Health 18, no. 10: 5237. https://doi.org/10.3390/ijerph18105237
APA StyleNik Ab Kadir, M. N., Mohd Hairon, S., Yaacob, N. M., Ab Manan, A., & Ali, N. (2021). Survival and Characteristics of Bladder Cancer: Analysis of the Malaysian National Cancer Registry. International Journal of Environmental Research and Public Health, 18(10), 5237. https://doi.org/10.3390/ijerph18105237